Generic Name: Insulin Aspart 30 Injection

English Name: Insulin Aspart 30 Injection

Chinese Phonetic Symbols: Mendong Yidaosu 30 Zhusheye

Composition: 1 ml of the suspension contains 100 units (100U) of soluble insulin aspart and protamine insulin aspart (equivalent to 3.5mg), with a ratio of 30: 70. The active ingredient of this product is insulin aspart (manufactured through gene recombination technology, by the using of yeasts).

Indication: UBLIN is indicated for the treatment of diabetes mellitus.

Strength: 3ml: 300 units (prefilled).

Dosage and administration: Individualize and adjust the dosage of UBLIN based on the patient’s medical conditions. This dosage form of the product shall only be used for subcutaneous injection, and shall not be used for intravenous administration, or intramuscular injection. This dosage form of the product cannot be administered using insulin pumps.

Packaging: the product is supplied in a single-use multi-dose injection pen preloaded with a glass cartridge (type I). The cartridge contains 3ml of the suspension liquid and is sealed at one end using a rubber plunger (bromobutyl rubber), and sealed at the other end with a rubber pad (bromobutyl rubber). The cartridge contains a glass bead inside to help facilitate a homogeneous mixing of the insulin suspension within. Each box contains one prefilled pen filled with 3 ml of the insulin suspension.

Shelf life: 18 months

Execution standard: YBS00662021

Approval number: National drug approval number S20210030